Role of type I interferon receptor signaling on NK cell development and functions

PLoS ONE

Volumn 9, Issue 10, 2014, Pages

  Guan, Jean ^a   Miah, S M Shahjahan ^a   Wilson, Zachary S ^a   Erick, Timothy K ^a   Banh, Cindy ^a   Brossay, Laurent ^a  

^a Division of Biology and Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD11B ANTIGEN; CD27 ANTIGEN; INTERFERON RECEPTOR; INTERFERON RECEPTOR 1; UNCLASSIFIED DRUG; ALPHA BETA INTERFERON RECEPTOR; GAMMA INTERFERON; IFNAR1 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW; CELL FUNCTION; CELL MATURATION; CELL PROLIFERATION; CONTROLLED STUDY; CROSS PRESENTATION; CYTOKINE PRODUCTION; DENDRITIC CELL; FLOW CYTOMETRY; LIVER; LYMPHOCYTE COUNT; MOUSE; NATURAL KILLER CELL; NONHUMAN; PROTEIN CROSS LINKING; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; TISSUE SPECIFICITY; ADOPTIVE TRANSFER; ANIMAL; ANTIBODY SPECIFICITY; BIOSYNTHESIS; BONE MARROW CELL; GENE EXPRESSION REGULATION; GENETICS; HUMAN; IMMUNOLOGY; INNATE IMMUNITY; METABOLISM; MUROMEGALOVIRUS; PATHOGENICITY; VIROLOGY;

ADOPTIVE TRANSFER; ANIMALS; BONE MARROW CELLS; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HUMANS; IMMUNITY, INNATE; INTERFERON-GAMMA; KILLER CELLS, NATURAL; LIVER; MICE; MUROMEGALOVIRUS; ORGAN SPECIFICITY; RECEPTOR, INTERFERON ALPHA-BETA; SIGNAL TRANSDUCTION;

EID: 84908205831     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0111302     Document Type: Article

References (37)

1. Spits H, Artis D, Colonna M, Diefenbach A, Di Santo JP, et al. (2013) Innate lymphoid cells - a proposal for uniform nomenclature. Nat Rev Immunol 13: 145-149.
2. Xu W, Di Santo JP (2013) Taming the Beast within: Regulation of Innate Lymphoid Cell Homeostasis and Function. The Journal of Immunology 191: 4489-4496.
3. Yu J, Freud AG, Caligiuri MA (2013) Location and cellular stages of natural killer cell development. Trends Immunol 34: 573-582.
4. Carotta S, Pang SH, Nutt SL, Belz GT (2011) Identification of the earliest NK-cell precursor in the mouse BM. Blood 117: 5449-5452.
5. Fathman JW, Bhattacharya D, Inlay MA, Seita J, Karsunky H, et al. (2011) Identification of the earliest natural killer cell-committed progenitor in murine bone marrow. Blood 118: 5439-5447.
6. Huntington ND, Nutt SL, Carotta S (2013) Regulation of murine natural killer cell commitment. Front Immunol 4: 14.
7. Martin-Fontecha A, Lord GM, Brady HJ (2011) Transcriptional control of natural killer cell differentiation and function. Cell Mol Life Sci 68: 3495-3503.
8. Gascoyne DM, Long E, Veiga-Fernandes H, de Boer J, Williams O, et al. (2009) The basic leucine zipper transcription factor E4BP4 is essential for natural killer cell development. Nat Immunol 10: 1118-1124.
9. Kamizono S, Duncan GS, Seidel MG, Morimoto A, Hamada K, et al. (2009) Nfil3/E4bp4 is required for the development and maturation of NK cells in vivo. J Exp Med 206: 2977-2986.
10. Male V, Nisoli I, Kostrzewski T, Allan DS, Carlyle JR, et al. (2014) The transcription factor E4bp4/Nfil3 controls commitment to the NK lineage and directly regulates Eomes and Id2 expression. J Exp Med 211: 635-642.
11. Trinchieri G (2010) Type I interferon: friend or foe? J Exp Med 207: 2053-2063.
12. Uze G, Schreiber G, Piehler J, Pellegrini S (2007) The receptor of the type I interferon family. Curr Top Microbiol Immunol 316: 71-95.
13. Muller U, Steinhoff U, Reis LF, Hemmi S, Pavlovic J, et al. (1994) Functional role of type I and type II interferons in antiviral defense. Science 264: 1918-1921.
14. Tessmer MS, Reilly EC, Brossay L (2011) Salivary gland NK cells are phenotypically and functionally unique. PLoS Pathog 7: e1001254.
15. Banh C, Miah SM, Kerr WG, Brossay L (2012) Mouse natural killer cell development and maturation are differentially regulated by SHIP-1. Blood 120: 4583-4590.
16. Henry SC, Schmader K, Brown TT, Miller SE, Howell DN, et al. (2000) Enhanced green fluorescent protein as a marker for localizing murine cytomegalovirus in acute and latent infection. J Virol Methods 89: 61-73.
17. Robbins SH, Nguyen KB, Takahashi N, Mikayama T, Biron CA, et al. (2002) Cutting edge: inhibitory functions of the killer cell lectin-like receptor G1 molecule during the activation of mouse NK cells. J Immunol 168: 2585-2589.
18. Chiossone L, Chaix J, Fuseri N, Roth C, Vivier E, et al. (2009) Maturation of mouse NK cells is a 4-stage developmental program. Blood 113: 5488-5496.
19. Rosmaraki EE, Douagi I, Roth C, Colucci F, Cumano A, et al. (2001) Identification of committed NK cell progenitors in adult murine bone marrow. Eur J Immunol 31: 1900-1909.
20. Essers MA, Offner S, Blanco-Bose WE, Waibler Z, Kalinke U, et al. (2009) IFNalpha activates dormant haematopoietic stem cells in vivo. Nature 458: 904-908.
21. Sato T, Onai N, Yoshihara H, Arai F, Suda T, et al. (2009) Interferon regulatory factor-2 protects quiescent hematopoietic stem cells from type I interferon-dependent exhaustion. Nat Med 15: 696-700.
22. Cella M, Miller H, Song C (2014) Beyond NK cells: the expanding universe of innate lymphoid cells. Front Immunol 5: 282.
23. Peng H, Jiang X, Chen Y, Sojka DK, Wei H, et al. (2013) Liver-resident NK cells confer adaptive immunity in skin-contact inflammation. J Clin Invest 123: 1444-1456.
24. Daussy C, Faure F, Mayol K, Viel S, Gasteiger G, et al. (2014) T-bet and Eomes instruct the development of two distinct natural killer cell lineages in the liver and in the bone marrow. J Exp Med 211: 563-577.
25. Sojka DK, Plougastel-Douglas B, Yang L, Pak-Wittel MA, Artyomov MN, et al. (2014) Tissue-resident natural killer (NK) cells are cell lineages distinct from thymic and conventional splenic NK cells. Elife 3: e01659.
26. Geurs TL, Zhao YM, Hill EB, French AR (2009) Ly49H engagement compensates for the absence of type I interferon signaling in stimulating NK cell proliferation during murine cytomegalovirus infection. J Immunol 183: 5830-5836.
27. Beuneu H, Deguine J, Bouvier I, Di Santo JP, Albert ML, et al. (2011) Cutting Edge: A dual role for type I IFNs during polyinosinic-polycytidylic acid-induced NK cell activation. J Immunol 187: 2084-2088.
28. Mattei F, Schiavoni G, Belardelli F, Tough DF (2001) IL-15 is expressed by dendritic cells in response to type I IFN, double-stranded RNA, or lipopolysaccharide and promotes dendritic cell activation. J Immunol 167: 1179-1187.
29. Lucas M, Schachterle W, Oberle K, Aichele P, Diefenbach A (2007) Dendritic cells prime natural killer cells by trans-presenting interleukin 15. Immunity 26: 503-517.
30. Mizutani T, Neugebauer N, Putz EM, Moritz N, Simma O, et al. (2012) Conditional IFNAR1 ablation reveals distinct requirements of Type I IFN signaling for NK cell maturation and tumor surveillance. Oncoimmunology 1: 1027-1037.
31. Hayakawa Y, Smyth MJ (2006) CD27 dissects mature NK cells into two subsets with distinct responsiveness and migratory capacity. J Immunol 176: 1517-1524.
32. Baranek T, Manh TP, Alexandre Y, Maqbool MA, Cabeza JZ, et al. (2012) Differential responses of immune cells to type I interferon contribute to host resistance to viral infection. Cell Host Microbe 12: 571-584.
33. Martinez J, Huang X, Yang Y (2008) Direct action of type I IFN on NK cells is required for their activation in response to vaccinia viral infection in vivo. J Immunol 180: 1592-1597.
34. Zhu J, Martinez J, Huang X, Yang Y (2007) Innate immunity against vaccinia virus is mediated by TLR2 and requires TLR-independent production of IFN-beta. Blood 109: 619-625.
35. Gill N, Chenoweth MJ, Verdu EF, Ashkar AA (2011) NK cells require type I IFN receptor for antiviral responses during genital HSV-2 infection. Cell Immunol 269: 29-37.
36. Nguyen KB, Salazar-Mather TP, Dalod MY, Van Deusen JB, Wei XQ, et al. (2002) Coordinated and distinct roles for IFN-alpha beta, IL-12, and IL-15 regulation of NK cell responses to viral infection. J Immunol 169: 4279-4287.
37. Fehniger TA, Cai SF, Cao X, Bredemeyer AJ, Presti RM, et al. (2007) Acquisition of murine NK cell cytotoxicity requires the translation of a preexisting pool of granzyme B and perforin mRNAs. Immunity 26: 798-811.